Patents
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
08/2011
08/17/2011CN102151260A Andrographolide and berberine combination and application thereof
08/17/2011CN102151256A Application of protocatechuic acid in preparation of drugs for preventing and controlling livestock and poultry virus infectious diseases
08/17/2011CN102151254A Jiekang disinfectant
08/17/2011CN102151245A Castor oil micro-emulsion for Nifeviroc anti-cancer medicine and preparation method thereof
08/17/2011CN102151242A In-situ gel slow-release preparation for anti-tuberculosis drugs and preparation method thereof
08/17/2011CN102150959A Air-permeable protective face fabric
08/17/2011CN101884776B Chinese preparation for treating hand-foot-and-mouth diseases
08/17/2011CN101845419B Recombinant adenovirus and application thereof
08/17/2011CN101843860B Chinese medicament for treating children cold
08/17/2011CN101843745B Chinese medicament for treating chronic hepatitis
08/17/2011CN101804140B Oral medicine for preventing and curing canine enteric bacterial disease
08/17/2011CN101780094B Slow-release preparation of cucurbitacin
08/17/2011CN101703768B Preparation method of vibrio parahaemolyticus outer membrane protein VP1061 and application of immunity protective function thereof
08/17/2011CN101703657B External preparation for treating verruca vulgaris
08/17/2011CN101703604B Medicament for treating dermatophytosis
08/17/2011CN101690810B Tetravalent inactivated vaccine adjuvant against Newcastle Disease, infectious bronchitis, egg drop syndrome and bird flu and preparation method thereof
08/17/2011CN101665481B Extraction method of eriosema chinense isoflavoid compound
08/17/2011CN101665480B Extraction method of eriosema chinense isoflavoid extract
08/17/2011CN101643471B C3/C3 fluoroquinolone dimmer derivative using oxadiazole as connection chain as well as preparation method and application thereof
08/17/2011CN101642572B Protective freezedrying powder of marine microorganism neuzyme and preparation method
08/17/2011CN101632747B Preparation technology of children cold relaxation grain
08/17/2011CN101602740B Method for extracting epigoitrin from isatis root
08/17/2011CN101596192B Application of palmatine in medicine for treating dengue virus infection
08/17/2011CN101596162B Doxycycline hyclate enteric-coated pellet
08/17/2011CN101538572B Recombinant lactic acid bacteria containing recombinant alpha-2b interferon and application thereof
08/17/2011CN101531630B Asymmetric chiral double-Schiff base simple synthesizing method
08/17/2011CN101497580B HIV-1 inhibitor 2-pyrrolidinone derivative, as well as synthesizing method and use thereof
08/17/2011CN101485817B Chinese medicinal composition for treating syphilis infection as well as preparation method and quality control method thereof
08/17/2011CN101479279B Penem prodrugs
08/17/2011CN101455736B Use of wild jujube seeds extract
08/17/2011CN101411873B Dual inactivated bacterin for ascites disease of cultivated flounder and preparation method
08/17/2011CN101336991B Medicine for treating gynaecologic pruritus vulvae and colpitis
08/17/2011CN101332297B Preparation method of novel subunit vaccine of pig pseudorabies
08/17/2011CN101250529B Horse infectious anemia virus soluble acceptor, coded sequence and uses thereof
08/17/2011CN101190232B Magnesium isoglycyrrhizinate freeze dried powder injection for injection and preparation method thereof
08/17/2011CN101189234B Heterobicyclic inhibitors of HCV
08/17/2011CN101184728B Peptide deformylase (PDF) inhibitors 4
08/17/2011CN101054393B Adefovir dipivoxil anhydrous crystal, preparation method and medicine composition thereof
08/16/2011US7999090 Fungal cell wall synthesis gene
08/16/2011US7998979 Antibacterial quinoline derivatives
08/16/2011US7998951 treating hepatitis C infection; 6-cyclohexyl-2,3-dihydro-5-phenyl-1,4-oxazino[2,3,4-hi]indole-9-carboxylic acid
08/16/2011US7998922 Process for treating fibroses with biocompatible polymer
08/16/2011US7998492 Methods and products related to treatment and prevention of hepatitis C virus infection
08/16/2011CA2614603C Azolo triazines and pyrimidines
08/16/2011CA2507716C Novel adaptor protein that binds to mammalian toll-like receptor 3, and gene thereof
08/16/2011CA2496731C Novel benzonaphthyridines
08/16/2011CA2487095C Elongase genes and uses thereof
08/16/2011CA2485903C Broadspectrum substituted benzisoxazole sulfonamide hiv protease inhibitors
08/16/2011CA2467773C Acyloxymethyl esters of c4-16 n-alkane-dicarboxylic acids for the treatment of acne and other related skin disorders
08/16/2011CA2456648C Human antibodies specific for interleukin 15 (il-15)
08/16/2011CA2450660C Lactone formulations and method of use
08/16/2011CA2449002C Enhancement of oral bioavailability of non-emulsified formulation of prodrug esters with lecithin
08/16/2011CA2401624C Photodynamic cellular and acellular organism eradication utilizing a photosensitive material and surfactant
08/16/2011CA2376164C Intermolecularly associating compounds, and aggregates comprising them
08/12/2011DE202010007074U1 Neue Darreichungsformen für Cineol New forms of cineole
08/11/2011WO2011097347A2 Bismuth-thiols as antiseptics for biomedical uses, including treatment of bacterial biofilms and other uses
08/11/2011WO2011096685A2 Wormwood pill containing 95% of wormwood ethyl alcohol extract that has inactivation efficacy of the h1n1 virus and the h9n2 avian influenza virus
08/11/2011WO2011096566A1 Adhesive patch for treatment of tinea unguium
08/11/2011WO2011096536A1 Novel synthetic glycolipid and use thereof
08/11/2011WO2011096377A1 Pyrrole compound
08/11/2011WO2011095939A1 Antimicrobial peptides of the cecropin family and therapeutic uses thereof
08/11/2011WO2011095768A1 Lantibiotic salts
08/11/2011WO2011095764A2 Antimicrobial compounds
08/11/2011WO2011095196A1 Hetaryl-[1,8]naphthyridine derivatives
08/11/2011WO2011094953A1 Compounds for the treatment and prevention of influenza
08/11/2011WO2011094823A1 Compounds for treating respiratory syncytial virus infections
08/11/2011WO2011066006A3 Methods for treating aids
08/11/2011WO2011057262A3 Treatment of infections with tp receptor antagonists
08/11/2011WO2011046901A3 Broad spectrum antiviral and methods of use
08/11/2011US20110197292 Delivery method
08/11/2011US20110196128 Murine zcytor17 ligand polynucleotides
08/11/2011US20110196029 Composition for treating influenza a (h1n1) virus and a preparation method therefor
08/11/2011US20110196027 Beta-lactones as antibacterial agents
08/11/2011US20110196014 Methionine analogs and methods of using same
08/11/2011US20110196012 Deuterated macrocyclic inhibitors of viral ns3 protease
08/11/2011US20110196007 Monocyclic cyanoenones and methods of use thereof
08/11/2011US20110195999 Novel antifungal agent containing heterocyclic compound
08/11/2011US20110195988 Pharmaceutical Composition
08/11/2011US20110195979 Compounds for the treatment and prevention of influenza
08/11/2011US20110195974 Methods of treating inflammatory conditions with adrenergic antagonists
08/11/2011US20110195969 Amide compounds as boosters of antivirals
08/11/2011US20110195965 Tetrahydro- and dihydroquinazolinones
08/11/2011US20110195961 Tricyclic oxazolidinone antibiotic compounds
08/11/2011US20110195949 2-benzothiophenyl- and 2-naphthyl-oxazolidinones and their azaisostere analogues as antibacterial agents
08/11/2011US20110195948 Substituted Pyrazolo[1,5-a]Pyrimidine Compounds as TRK Kinase Inhibitors
08/11/2011US20110195944 Modified release emulsions for application to skin or vaginal mucosa
08/11/2011US20110195940 Protease Inhibitors Having Enhanced Features
08/11/2011US20110195939 Antitumor properties of no modified protease inhibitors
08/11/2011US20110195929 Compounds for the treatment of flaviviral infections
08/11/2011US20110195922 Beta-L-2'-Deoxy-Nucleosides for the Treatment of Hepatitis B
08/11/2011US20110195920 Biodefenses using triazole-containing macrolides
08/11/2011US20110195918 Method for producing pectin hydrolysis products
08/11/2011US20110195912 Oligomer-Protease Inhibitor Conjugates
08/11/2011US20110195894 Cd5 pharmaceutical compositions for the treatment of infectious and inflammatory processes of fungal origin
08/11/2011US20110195135 Anti-avian influenza virus agent, and product containing anti-avian influenza virus agent
08/11/2011US20110195132 Self-Preserved Aqueous Pharmaceutical Compositions
08/11/2011US20110195113 Virus-like particles comprising composite capsid amino acid sequences for enhanced cross reactivity
08/11/2011US20110195094 Triazole compounds that modulate hsp90 activity
08/11/2011US20110195092 Live attenuated aldolase-negative bacterial vaccine
08/11/2011US20110195090 Method of making a vaccine